OCT Medical Devices Europe 2026
Share
.png)
Event details
Join industry leaders and regulatory experts at OCT Medical Devices Europe 2026, a complimentary two-day conference focused on accelerating clinical trials for medical devices, diagnostics and combination products.
Gain practical insight into MDR, IVDR, the AI Act and HTA requirements, explore effective clinical and real-world evidence strategies, and connect with 120+ MedTech professionals, 20+ solution providers and 15+ expert speakers from across the ecosystem.
.png?width=600&height=400&name=14th%20Annual%20Outsourcing%20in%20Clinical%20Trials%20Medical%20Devices%20Europe%202026%20(1).png)
We’re speaking at the 14th Annual Outsourcing in Clinical Trials (OCT)
QbD Group will be actively involved in the programme at OCT Medical Devices Europe 2026. Our expert Petra De Geest will join a panel discussion on Wednesday, 28 January at 10:30 AM, “Building and scaling clinical affairs teams with the right expertise.”
The session will explore how organisations can balance in-house capabilities with outsourced support, define key roles across Clinical Affairs, from CER writing to PMCF strategy, and create sustainable career pathways for clinical evidence specialists.
Moderated by Dr Sarah Johnson, VP and Head of Clinical Affairs at QIAGEN, the panel brings together senior Clinical Affairs leaders to share practical perspectives on building robust evidence-focused teams under evolving regulatory expectations.
You can also meet our experts at Booth 18 to continue the conversation and discuss your clinical and regulatory challenges in more detail.
Connect with our team of experts
We invite you to connect with our team at OCT Medical Devices Europe 2026. Whether you are looking to strengthen your clinical evidence strategy, navigate MDR and IVDR requirements, or explore how to effectively build and scale your Clinical Affairs capabilities, QbD Group is here to support you.
Meet our experts during the event or get in touch with us in advance to arrange a conversation.
